Abstract:Introduction: Progranulin (PGRN) is a secreted glycoprotein, the expression of which is linked to several neurodegenerative diseases. Although its specific function is still unclear, several studies have linked it with lysosomal functions and immune system regulation. Here, we have explored the role of PGRN in peripheral and central immune system homeostasis by investigating the consequences of PGRN deficiency on adaptive and innate immune cell populations. Methods: First, we used gene co-expression network analysis of published data to test the hypothesis that Grn has a critical role in regulating the activation status of immune cell populations in both central and peripheral compartments. To investigate the extent to which PGRN-deficiency resulted in immune dysregulation, we performed deep immunophenotyping by flow cytometry of 19-24-month old male and female Grn-deficient mice (PGRN KO) and littermate Grn-sufficient controls (WT). Results: Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8+ T cells compared to WT mice. Furthermore, we observed an increase in CD44 on CD8+ T cells in the peripheral blood. Female PGRN KO mice also had fewer microglia compared to WT mice, and we also observed reduced expression of MHC-II on brain monocytes. Additionally, we found an increase in Ly-6Chigh monocyte frequency and decreased CD44 expression on CD8+ and CD4+ T cells in PGRN KO female blood. Given that Gpnmb, which encodes for the lysosomal protein Glycoprotein non-metastatic melanoma protein B, has been reported to be upregulated in PGRN KO mice, we investigated changes in GPNMB protein expression associated with PGRN deficits and found that GPNMB is modulated in myeloid cells in a sex-specific manner. Discussion: Our data suggest that PGRN and GPNMB jointly regulate the peripheral and the central immune system in a sex-specific manner; thus, understanding their associated mechanisms could pave the way for developing new neuroprotective strategies to modulate central and peripheral inflammation to lower risk for neurodegenerative diseases and possibly delay or halt progression.

Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases

The Role of Progranulin (PGRN) in the Pathogenesis of Ischemic Stroke

Potential Role of Full-Length and Nonfull-Length Progranulin in Affecting Aortic Valve Calcification.

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

Progranulin Controls Sepsis Via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.

Therapeutic Potential of Progranulin in Hyperhomocysteinemia-Induced Cardiorenal Dysfunction.

Adjusted vascular contractility relies on integrity of progranulin pathway: Insights into mitochondrial function

Progranulin is essential for bone homeostasis and immunology

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases

Progranulin Facilitates Conversion and Function of Regulatory T Cells under Inflammatory Conditions

Progranulin Suppressed Autoimmune Uveitis and Autoimmune Neuroinflammation by Inhibiting Th1/Th17 Cells and Promoting Treg Cells and M2 Macrophages

PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner

PGRN Exerts Inflammatory Effects Via SIRT1-NF-κB in Adipose Insulin Resistance.

Progranulin Protects Against Renal Ischemia/reperfusion Injury in Mice.

Circulating PGRN is significantly associated with systemic insulin sensitivity and autophagic activity in metabolic syndrome.

Progranulin is Highly Expressed in Patients with Chronic Periodontitis and Protects Against Experimental Periodontitis in Rats

Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances

Progranulin Protects Against Cerebral Ischemia-Reperfusion (I/R) Injury by Inhibiting Necroptosis and Oxidative Stress.

Progranulin Ameliorates Lung Inflammation in an LPS-induced Acute Lung Injury Mouse Model by Modulating Macrophage Polarization and the MAPK Pathway

Progranulin as a therapeutic target in neurodegenerative diseases

Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system